Calliditas Therapeutics Ab (CALT) has released an update.
Calliditas Therapeutics AB has announced its annual general meeting (AGM) for shareholders, scheduled for June 17, 2024, in Stockholm. Shareholders wishing to attend must be registered by June 7 and notify their participation by June 11. The agenda includes corporate governance matters and incentive programs, with options for both in-person attendance and advance voting.
For further insights into CALT stock, check out TipRanks’ Stock Analysis page.
